logo-loader
RNS
viewIntegumen

Integumen PLC - Replacement:Exercise of Warrants;TVR

RNS Number : 3784O
Integumen PLC
29 May 2020
 

The following amendment has been made to the 'Exercise of Warrants; Total voting rights' announcement released on 28 May 2020 at 15:30 under RNS No 2634O. The announcement now includes the expected admission date of the Warrant Shares.

 

All other details remain unchanged.

 

The full amended text is shown below.

 

AIM share code: SKIN

29 May 2019

 

Integumen PLC

 

("Integumen" or "Company")

 

 

Exercise of Warrants

 

Integumen announces that it has received notification from a warrant holder to exercise warrants over 3,000,000 shares in the share capital of Integumen ("the Warrant Shares"). The consideration for the exercise of the Warrant Shares amounts, in aggregate, to a cash value of £45,000.

 

Total voting rights

 

The Warrant Shares were allotted on 28 May 2020. Application has been made for the Warrant Shares to be admitted to trading on AIM ("Admission"), and Admission is expected to be on or about 3 June 2020. These shares will rank pari passu with the ordinary shares of the Company in issue.

 

The Company's total issued share capital, following the issue of the Warrant Shares, will be 1,075,416,903 ordinary shares. As the Company does not hold any shares in Treasury, this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company following Admission.

 

 

Integumen plc

Gerard Brandon, CEO

+44 (0) 7340 055 648




SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin/Andrew Emmott

+44 (0) 113 370 8974




Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/Zoe Alexander

+44 (0) 20 3657 0050




 

About Integumen plc:

Integumen is a scientific research and AI-as-a-Service company focused on production and analysis of bacteria, virus and toxins utilising artificial intelligent data analytics in regulatory technology, from scientifically proving the impact of skincare product claims on skin microbiome for top 10 global cosmetic company clients to remotely detecting water contamination in real-time.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
TVREANSNALAEEEA

Quick facts: Integumen

Price: 1.9

Market: AIM
Market Cap: £20.5 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE